Sources

4 Total Sources

Patients Gain Access to Daraxonrasib After Trial Doubled Survival to 13.2 Months

The Boston Globe7d ago
Patients Access Experimental Drug Daraxonrasib for Advanced Pancreatic Cancer
Reuters7d ago
Promising Revolution Medicines pancreatic cancer drug has high rate of mostly manageable side effects | Reuters
clinicaltrialvanguard.com7d ago
Daraxonrasib Halves Death Risk in Phase 3 Pancreatic Cancer Trial
St. George News8d ago
A big leap forward': St. George Regional Hospital begins use of new pancreatic cancer treatment | News | stgeorgeutah.com